Central African Republic (the)

in page functions
[French]
Central African Republic
Total population (2017) 5,098,810
Birth cohort (2017) 166,656
Surviving Infants (surviving to 1 year per year, 2017) 152,583
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 92/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 130/1000
World Bank Index, IDA (2015) 2.46
Gross Nation Income (per capita US$, 2015) 330
Co-financing group (2017) Initial self-financing
No. of districts/territories (2015) 30

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Central African Republic

Type of support

Approvals

2001-2021 (US$)
(25 Apr 2017)

Commitments

2001-2021 (US$)
(25 Apr 2017)

Disbursements

2000-2017 (US$)
(25 Apr 2017)

% Disbursed

(25 Apr 2017)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Total $32,810,378 $33,078,878 $33,269,093
Health system strengthening (HSS 1) $3,163,000 $3,163,000 $3,163,000 100%
Immunisation services support (ISS) $1,611,360 $1,879,860 $1,611,360 100%
Injection Safety Devices (NVS) $52,000 $52,000 $63,332 122%
Injection safety support (INS) $119,651 $119,651 $119,651 100%
IPV (NVS) $359,881 $359,881 $215,216 60%
Meningitis A (NVS) $104,500 $104,500 $103,303 99%
Meningitis A - campaign (NVS) $2,933,000 $2,933,000 $3,106,647 106%
Meningitis A - operational costs (OPC) $2,342,943 $2,342,943 $2,342,943 100%
Penta (NVS) $8,251,257 $8,251,257 $7,973,683 97%
Pneumo (NVS) $11,178,150 $11,178,150 $12,150,175 109%
Rotavirus (NVS) $194,000 $194,000 0%
Vaccine Introduction Grant (VIG) $703,586 $703,586 $564,586 80%
Yellow Fever (NVS) $1,797,050 $1,797,050 $1,855,197 103%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Central African Republic DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 47%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2009) 33.10%
Household survey: DTP3 coverage for female (2009) 31.10%
Household survey: Last DTP3 survey (2009) 32%
% districts achieving > 80% DTP3 coverage (2015) 7%
% districts achieving < 50% DTP3 coverage (2015) 53%
MCV WHO/UNICEF estimates (2015) 49%

Breakdown of support

Non-vaccine support Vaccine support
23% 77%
$7,801,540 $25,467,553

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Central African Republic

25 April 2017

Central African Republic, a mother and her two children.

Central African Republic: mother spreads word about meningitis A vaccine

Izimili Raude knows that her community must rely on vaccines, not miracles, to spare children from a deadly disease.

19 September 2016

Stockpiling

On the frontline: Gavi's support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

close icon

modal window here